FDA Grants Standalone Approval for Novel Nasal Spray Antidepressant Spravato (Esketamine)
Spravato, the trade name for esketamine, now has a newly sanctioned use for treatment-resistant depression. tadamichi/Getty Images/iStockphoto/iStockphoto hide caption toggle…
FDA Grants Standalone Approval for Novel Nasal Spray Antidepressant Spravato (Esketamine) Read More